Literature DB >> 2044396

A multi-centre comparative study of diclofenac sodium and a dipyrone/spasmolytic combination, and a single-centre comparative study of diclofenac sodium and pethidine in renal colic patients in India.

K V Marthak1, A M Gokarn, A V Rao, S P Sane, R K Mahanta, R D Sheth, K D Chavda, B S Rane, A B Vaidya.   

Abstract

A single-blind, randomized clinical trial was carried out to compare the analgesic effectiveness in patients with renal colic of single intramuscular doses of diclofenac sodium (75 mg) versus a dipyrone (1 g)/spasmolytics combination, and diclofenac sodium (75 mg) versus pethidine (75 mg). The first study involved three centres, the second study one centre. In total, 107 patients were treated with diclofenac sodium, 85 with dipyrone/spasmolytics, and 25 with pethidine. Assessments were made during the first hour after drug administration of the degree of pain relief, the severity of pain using a visual analogue scale, and the duration of analgesia. A global assessment of treatment efficacy was made by the participating physicians at the end of the study period. Patients treated with diclofenac sodium showed an earlier onset of analgesia and a higher incidence of total pain relief compared to those treated with dipyrone/spasmolytics or pethidine. Although the mean duration of analgesia was only slightly greater in the diclofenac sodium group than in the dipyrone/spasmolytics group, a significantly longer effect was seen when diclofenac sodium was compared with pethidine (p less than 0.01). Pain severity assessments revealed that diclofenac sodium caused a significantly greater improvement in pain after 60 minutes compared to dipyrone/spasmolytics (p less than 0.05) and after 30 minutes compared to pethidine (p less than 0.05). Global efficacy assessments by the physician rated diclofenac sodium as significantly superior to dipyrone/spasmolytics (p less than 0.01) and pethidine (p less than 0.001). Moreover, diclofenac sodium was better tolerated than either of the comparative treatments. The results indicate that intramuscular diclofenac sodium is a useful alternative to the drugs commonly used in India in the treatment of renal colic.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2044396     DOI: 10.1185/03007999109111506

Source DB:  PubMed          Journal:  Curr Med Res Opin        ISSN: 0300-7995            Impact factor:   2.580


  6 in total

Review 1.  Nonsteroidal anti-inflammatory drugs (NSAIDs) versus opioids for acute renal colic.

Authors:  A Holdgate; T Pollock
Journal:  Cochrane Database Syst Rev       Date:  2005-04-18

2.  Ondansetron versus diclofenac sodium in the treatment of acute ureteral colic: a double blind controlled trial.

Authors:  U Ergene; M Pekdemir; E Canda; Z Kirkali; J Fowler; F Coşkun
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

Review 3.  Systematic review of the relative efficacy of non-steroidal anti-inflammatory drugs and opioids in the treatment of acute renal colic.

Authors:  Anna Holdgate; Tamara Pollock
Journal:  BMJ       Date:  2004-06-03

4.  [Pain therapy in acute renal colic.].

Authors:  C Tschuschke; S C Müller; L Hertle
Journal:  Schmerz       Date:  1993-09       Impact factor: 1.107

5.  Increasing Nonsteroidal Anti-inflammatory Drugs and Reducing Opioids or Paracetamol in the Management of Acute Renal Colic: Based on Three-Stage Study Design of Network Meta-Analysis of Randomized Controlled Trials.

Authors:  Hui-Yun Gu; Jie Luo; Jun-Yi Wu; Qi-Sheng Yao; Yu-Ming Niu; Chao Zhang
Journal:  Front Pharmacol       Date:  2019-02-22       Impact factor: 5.810

Review 6.  Comparison of the Efficacy of Nonsteroidal Anti-Inflammatory Drugs and Opioids in the Treatment of Acute Renal Colic: A Systematic Review and Meta-Analysis.

Authors:  Xie-Yuan Leng; Chang-Ning Liu; Shi-Chan Wang; Hao-Dong Peng; De-Guang Wang; Hai-Feng Pan
Journal:  Front Pharmacol       Date:  2022-01-27       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.